Overview
Takeshi Okatani practices practicing medicine in Hiroshima, Japan.
Mr. Okatani is highly rated in 1 condition, according to our data. His clinical expertise encompasses Familial Wilms Tumor 2, Chronic Graft Versus Host Disease (cGvHD), Non-Hodgkin Lymphoma, T-Cell Lymphoma, and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takeshi Okatani
Is Takeshi Okatani a top-rated expert for Familial Wilms Tumor 2?
MediFind is an objective health platform that identifies experts based on real-world data. Takeshi Okatani is classified as an Advanced expert for Familial Wilms Tumor 2, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takeshi Okatani participate in research or clinical trials?
Yes. Takeshi Okatani has published 14 articles and abstracts on conditions like Familial Wilms Tumor 2. You can view a list of Takeshi Okatani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Wilms Tumor 2Mr. Okatani isAdvanced. Learn about Familial Wilms Tumor 2.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Okatani isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaMr. Okatani isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloid Leukemia (AML)Mr. Okatani isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Okatani isExperienced. Learn about Agranulocytosis.
- AspergillosisMr. Okatani isExperienced. Learn about Aspergillosis.
- B-Cell LymphomaMr. Okatani isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Okatani isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Mr. Okatani isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Okatani isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hodgkin LymphomaMr. Okatani isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaMr. Okatani isExperienced. Learn about Leukemia.
- MononucleosisMr. Okatani isExperienced. Learn about Mononucleosis.
- Myelodysplastic Syndrome (MDS)Mr. Okatani isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Neurotoxicity SyndromesMr. Okatani isExperienced. Learn about Neurotoxicity Syndromes.
- Non-Hodgkin LymphomaMr. Okatani isExperienced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMr. Okatani isExperienced. Learn about Peripheral T-Cell Lymphoma.
- T-Cell LymphomaMr. Okatani isExperienced. Learn about T-Cell Lymphoma.